ActHIB Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam
Conditions: Meningococcal Infection (Healthy Volunteers) Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine Sponsors: Sanofi Pasteur, a Sanofi Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa
Condition: Meningococcal Infection (Healthy Volunteers) Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine; Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine; Biological: Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV); Biologica l: Pneumoccocal Vaccine; Biological: Measles, Mumps, and Rubella Vaccine live (MMR); Biological: DTwP-HepB-Hib-IPV vaccine; Biological: DTaP-IPV-Hib-HepB vaccine; Biological: Hepatitis A vaccine; Biological: Rotavirus vaccine; ...
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a Booster Dose in Children Vaccinated 5 Years Earlier as Toddlers
Condition: Meningococcal Infection Intervention: Biological: Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine Sponsor: Sanofi Pasteur, a Sanofi Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2021 Category: Research Source Type: clinical trials